Merck Tbk PT

Merck Tbk PT FCF per Share

The Free Cash Flow per Share of Merck Tbk PT (MERK.JK) as of Oct 17, 2026 is 805.58 IDR. In the previous year, Free Cash Flow per Share was 86.79 IDR — a change of 828.24% (higher).

FCF per Share

805.58IDR

YoY

828.24%

Last updated:

Free Cash Flow per Share of Merck Tbk PT is 2025 805.58 IDR. Free Cash Flow per Share of Merck Tbk PT was 2024 86.79 IDR. It decreases by 828.24% higher compared to the previous year.

The Merck Tbk PT FCF per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF per Share
Date
FCF per Share
Jan 1, 2018
323.89 IDR
Jan 1, 2019
-537.38 IDR
Jan 1, 2020
90.53 IDR
Jan 1, 2021
282.86 IDR
Jan 1, 2022
201.20 IDR
Jan 1, 2023
410.65 IDR
Jan 1, 2024
86.79 IDR
Jan 1, 2025
805.58 IDR
The Merck Tbk PT FCF per Share history
YEARFCF per ShareYoY
805.58IDR+828.24%
86.79IDR-78.87%
410.65IDR+104.10%
201.20IDR-28.87%
282.86IDR+212.44%
90.53IDR-116.85%
-537.38IDR-265.91%
323.89IDR+125.38%
143.71IDR+251.60%
40.87IDR-82.02%
227.31IDR-51.36%
467.32IDR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Merck Tbk PT Stock analysis

What does Merck Tbk PT do? Merck Tbk PT is a pharmaceutical company based in Jakarta Timur, DKI Jakarta, operating within the Health Care sector. The company, listed on the Indonesian stock exchange with ticker MERK.JK and ISIN ID1000136609, has been publicly traded since its IPO on July 23, 1981. It employs 376 full-time staff and focuses on the development and distribution of pharmaceutical and chemical products. The company operates through three business segments: Biopharma, which covers ethical pharmaceutical products; Consumer Health, which includes over-the-counter products; and Others, which encompasses additional business activities. Merck Tbk PT is committed to providing personalized treatments for serious diseases and supports initiatives related to reproductive health, including enabling individuals to achieve their goal of becoming parents. The company's official website is https://www.merckgroup.com/id-id, where further information about its operations and services can be accessed. As a publicly listed entity, Merck Tbk PT is subject to regulatory disclosures and financial reporting requirements in Indonesia. The company's primary focus remains on delivering healthcare solutions through its pharmaceutical and chemical offerings, targeting both professional medical markets and consumer health needs. Merck Tbk PT is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Merck Tbk PT stock

Free Cash Flow per Share of Merck Tbk PT is 805.58 IDR in 2025.

Free Cash Flow per Share of Merck Tbk PT changed from 86.79 IDR to 805.58 IDR, representing a 828.24% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow per Share Merck Tbk PT since 2006 – with annual values, charts, and detailed analysis.

FCF per share measures the free cash flow allocated to each outstanding share. It is a key metric for assessing shareholder value creation.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Merck Tbk PT

All Key Metrics — Merck Tbk PT